A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the treatment of Diabetic Macular Edema

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61989592%3A15110%2F11%3A33119263" target="_blank" >RIV/61989592:15110/11:33119263 - isvavai.cz</a>

Alternative codes found

RIV/00179906:_____/11:10105563

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the treatment of Diabetic Macular Edema

Original language description

Diabetic retinopathy (DR), a vascular copmplication of both types 1 and 2 diabetes, is correlated with the duration of the underlying disease. A leading cause of acquired visual loss in adults worldwide, DR is a major cause of morbidity in the working-agend population.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FF - ENT (ie. ear, nose, throat), ophthalmology, dentistry

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2011

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Ophthalmology

ISSN

0161-6420

e-ISSN

—

Volume of the periodical

118

Issue of the periodical within the volume

6

Country of publishing house

US - UNITED STATES

Number of pages

12

Pages from-to

1107-1118

UT code for WoS article

—

EID of the result in the Scopus database

—